Blog

Organization hosts river cleanup to support river conservation and awareness

BIG SKY, MT / ACCESS Newswire / July 9, 2025 / Rivers are Life, a global conservation movement headquartered in Michigan that invests in the protection of rivers around the world, announced today its participation at this year’s Wildlands music event in Big Sky, Montana. An event that is focused on supporting outdoor conservation and bringing outdoor enthusiasts together around a common cause, Rivers are Life will assist in kicking this year’s event off by hosting a river cleanup for attendees on Friday, August 1st.

In partnership with Outlaw Partners and the Wildlands event, Rivers are Life will host a river cleanup focusing on stopping trash from getting into one of Montana’s most iconic waterways, the Gallatin River. Meet at the Big Sky Events Arena and join forces with other passionate organizations – American Rivers, Center for Large Landscapes, and the Gallatin River Task Force on Friday, August 1, from 10am until 1pm. This river cleanup follows the Wildlands Charity Night, which supports the incredible boots-on-the-ground initiatives being done by American Rivers and the Center for Large Landscape Conservation. Those interested in participating in Friday’s cleanup can head to this link to sign up now.

“We are so excited to be part of this year’s Wildlands Festival, spending time in beautiful Montana alongside like-minded brands and people who understand the importance of conserving our environment,” said Katie Horning, VP of Marketing at Rivers are Life. “It’s amazing to see this crowd come together through music and a shared love for the outdoors. This year marks our first-ever river cleanup at the festival, and we’re especially proud to roll up our sleeves-because taking action on the ground is how real change begins. We’re honored to support this cause and help raise awareness for river conservation.”

“We’re grateful to have partners like Rivers are Life who support through action,” said Megan Paulson, Co-founder and CMO of Outlaw Partners. “Their passion for rivers and the overall ethos of Wildlands through the river cleanup event is a meaningful way that will make a direct impact here in Montana.”

This year’s Wildlands lineup features two nights of Dave Matthews as the headliner on Friday, August 1 and Saturday, August 2 where he will take the stage in Montana for the first time in 30 years. Wildlands celebrates the wild lands and incredible spaces that surround us through music and personal connection by directly supporting this year’s event beneficiaries: American Rivers and Center for Large Landscape Conservation.

Stay up to date on the latest conservation efforts from Rivers are Life by following on Instagram and learn more about the River Action membership program by heading to RiversareLife.com.

Contact Information:

Katie Horning
VP of Marketing, Rivers are Life
khorning@riversarelife.com
989-491-1019

SOURCE: Rivers are Life

View the original press release on ACCESS Newswire

• Early positive consumer testimonials from initial Company product sampling

• Sublingual nano technology delivers caffeine rapidly to the bloodstream, bringing its unique benefits to the pre-workout market

• Developed through over a decade of scientific research to deliver a patent-pending, fast-acting supplement formulation for maximum effect

• Completed initial production in four flavors

• Aspire to launch BUZZ BOMB™ at the FITCON and Fit Expo conventions in August

ESTERO, FL AND NEW YORK, NY / ACCESS Newswire / July 9, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) (“Aspire” or the “Company”), developer of a multi-faceted patent-pending supplement delivery technology, today announced positive initial consumer feedback from the Company’s sampling of its sublingual pre-workout supplement, BUZZ BOMB™. Featuring 50mg of caffeine and designed to support sustained energy and mental focus, BUZZ BOMB™ is bringing its unique delivery technology benefits to the multi-billion-dollar pre-workout market to help athletes and fitness enthusiasts maximize their performance potential. Buzz Bomb™ provides nearly instant energy, in easy-to-use small sublingual packets, which can be taken right before and during work out as needed.

Last month, BUZZ BOMB™ began a soft launch of its product line, introducing it to strength trainers, consultants, and fitness professionals. Aspire sees BUZZ BOMB™ as more than just another supplement; it is a science-driven brand focused on understanding nutrition, performance, and the daily needs of athletes and fitness enthusiasts. BUZZ BOMB™ is a pre-workout solution that boosts endurance, energy metabolism, and overall performance, primarily through caffeine, a well-researched ingredient shown to enhance fitness results. Unlike pre-workout products that are mixed with water and taken well before a workout, BUZZ BOMB is sprinkled under the tongue for immediate effect.

TESTEMONIALS

“As a professional trainer, I have used Buzz Bomb to enhance my own workouts, and I will recommend it to all my clients as soon as it is available. When clients feel more energy and are more successful with their workout, it reflects well on me as a trainer, and they want to keep up their training with me. It will be a win-win for both of us!
Grace M.
Professional Trainer & Body Building Competitor

“I love Buzz Bomb! I can take it at the gym right before my workout. By the time I get my spinning shoes on, I’m good-to-go! It makes the workout so much easier.
Jennifer C.
Insurance Rep & Mother of Three

“I’ve seen a lot of pre-workout products in my gym, but this is the one I plan to recommend the most. It’s the fastest and easiest to use. No messy liquids, mixing or waiting around for it to kick in.”
London S.
Gym Owner

Aspire has started initial production of BUZZ BOMB™. The product is packaged in single serving packets for easy on-the-go use. Consumers will have a choice of four BUZZ BOMB™ flavors, including Tropical Fruit, Mixed Berry, Peach Mango, and Mocha Coffee, sold in 30 unit-packs.

“BUZZ BOMB™ is a key first step in our strategy to leverage the full potential of our sublingual nano technology. Our goal is to create a healthy, transformational, next-generation pre-workout brand,” said Michael Howe, Chief Executive Officer of Aspire. “The feedback from our initial product sampling with consumers, as recounted by numerous testimonials, has been very positive and encouraging. We learned that whether you’re hitting the gym, the trail, or just need to show up strong for your day, BUZZ BOMB™ delivers energy very quickly in a convenient easy-to-use single serving packet. We believe this brand has the potential to become a go-to energy supplement for athletes as well as consumers seeking an energy boost that fits their lifestyle requirements.”

Howe added, “We are excited about launching BUZZ BOMB™ at two of the major fitness conventions in early August. Aspire will be an event sponsor at both conferences where over 50,000 people interested in health, fitness optimization, nutrition, and overall well-being will be able to taste, sample, and experience the BUZZ BOMB™ pre-workout supplement.”

Howe concluded, “Aspire plans to follow up the launch of BUZZ BOMB™ with several other consumer products in the nutraceutical and supplement categories. These products have the potential to generate revenue for Aspire while we evaluate licensing opportunities with established companies in these industries.”

BUZZ BOMB™ Pre-workout Benefits:

• Speed – works nearly immediate vs. 20-30 minutes

• Convenience – easy to use single-use packets vs. mixing and measuring for beverages

• Energy management – use as needed to precisely manage caffeine intake

• Single Safe Active Ingredient – well-known benefits and use of caffeine

• Low manufacturing & packaging costs – competitive pricing with high margin potential

Pre-workout Supplements Market & Growth Drivers

According to Research and Market Reports recent report, “The global pre-workout supplements market size is expected to reach $27.97 billion by 2030, registering a CAGR of 5.9% from 2025 to 2030.”

About the Aspire Targeted Oral Delivery Platform

Aspire’s technology delivers fast-acting supplement formulations which have been developed by using our patent-pending methodology, and “trade secret” process. The technology’s new mechanism of action allows for rapid sublingual absorption. The benefits of “rapid absorption” are to provide rapid impact in more precise quantities.

About Aspire Biopharma, Inc.

Headquartered in Estero, Fl., Aspire Biopharma has developed a disruptive technology that can deliver supplements and drugs rapidly and precisely. For more information, please visit www.aspirebiolabs.com.

Safe Harbor Statement

Certain statements made in this communication are “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may generally be identified by the use of words such as “estimate,” “projects,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “would,” “should,” “future,” “propose,” “potential,” “target,” “goal,” “objective,” “outlook” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements include, but are not limited to, statements regarding the financial position, business strategy and the plans and objectives of management for future operations. These statements are based on various assumptions, whether or not identified in this communication, and on the current expectations of Aspire’s management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as and must not be relied on by any investor as a guarantee, an assurance, a prediction or a definitive statement of fact or probability. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the control of the parties, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Aspire Biopharma Holdings, Inc.

Contact

PCG Advisory
Kevin McGrath
+1-646-418-7002
kevin@pcgadvisory.com

SOURCE: Aspire Biopharma Holdings, Inc.

View the original press release on ACCESS Newswire

SINGAPORE, SG / ACCESS Newswire / July 9, 2025 / Augmentus, the developer of an intelligent no-code robotics solution, announced today that it has raised USD $11 million (SGD $14 million) in a Series A+ funding round. The funds will be used to accelerate regional deployment of its fully autonomous robotic surface finishing and welding systems, fulfill demand from marquee manufacturing customers, and advance R&D into hyper-adaptive, AI-driven robotic systems built for the factory floor.

The round was led by Woori VP, with participation from new investor EDBI, alongside returning backers Sierra Ventures and Cocoon Capital.

“We’re seeing unprecedented demand-and this round enables us to deliver. It allows us to fulfill our growing backlog while accelerating R&D into hyper-adaptive robotics that can perceive and respond on the fly, even in chaotic, high-mix environments where no two parts are alike. These are the hardest problems in automation-surface finishing, material removal, welding-and we’re solving them at scale,” said Daryl Lim, Co-founder and CEO of Augmentus. “With world-class partners across Asia, the U.S., and Europe, we’re not just building robotic software – we’re building the future of intelligent manufacturing.”

Solving the Core Bottleneck in Manufacturing Automation

Despite growing interest in robotics, most manufacturers are held back by the same challenge: programming remains complex, time-consuming, and rigid-especially in high-mix, low-volume environments.

Augmentus directly addresses this bottleneck. Acting as both the eyes and the brain of the robot, its system eliminates the need for manual coding by combining industrial 3D scanning, AI-driven path planning, and adaptive motion control. Robot programs are generated in minutes, not days-enabling manufacturers to automate even the most variable, geometry-sensitive tasks without the need for robotics experts or production downtime.

“We’re not here to add another buzzword to the mix,” Lim added. “We’re here to deliver working systems that solve real problems-and that’s what this funding allows us to scale.”

Scaling with End Users and Integrators

With over 50 systems sold across more than 6 countries-including Australia, Singapore, North America, and Germany-Augmentus is now focused on scaling execution capacity and delivery. This next phase of growth will be driven by a two-pronged approach: direct engagement with end clients, and a growing network of trusted system integrators. Both play a critical role in extending reach, enabling local support, and embedding Augmentus’ solution into existing production workflows.

“Collaborating with Augmentus has enabled us to bring a new level of flexibility and reliability to shot peening automation. Their 3D scanning and AI-powered path planning technology complements our expertise in shot peening, resulting in systems that are easier to deploy, faster to set up, and capable of handling a wide variety of parts with confidence. Throughout our partnership, Augmentus has demonstrated a strong commitment to practical innovation and shared knowledge, helping us deliver advanced automation solutions that meet the evolving needs of our customers,” said Volker Schneidau, Managing Director of sentenso GmbH, an Augmentus system integrator partner.

The new capital will also support regional expansion across APAC and North America, while ensuring that booked systems for existing customers are delivered on time, at scale, and with full support infrastructure.

Building the Next Generation of Adaptive Automation with Augmented Robotics

With this raise, Augmentus will accelerate development of Augmented Robotics-a new class of hyper-adaptive systems capable of real-time adjustment to part variation, orientation shifts, and dynamic in-process feedback. These capabilities are essential for realizing the vision of closed-loop, autonomous manufacturing.

AI is not a buzzword in this context-it’s the core intelligence layer powering motion adaptation, process optimization, and flexible deployment across high-mix, path-sensitive operations. By combining industrial 3D scanning, AI path planning, and adaptive motion control, Augmentus is enabling robots to handle complexity that once required human intuition.

From Concept to Commercial Reality

While much of the robotics space remains in the pilot phase, Augmentus has moved into full-scale commercial deployment. Its solution has helped manufacturers cut programming time by up to 90%, reduce robot downtime from hours to minutes, and significantly lower the barrier to automation for non-technical teams. This shift enables manufacturers to realize faster ROI, particularly in industries where high product variability has historically made automation unviable.

About Augmentus

Augmentus enables manufacturers to automate complex industrial processes without coding or robotics expertise. Its intelligent, no-code solution integrates 3D scanning, automatic toolpath generation, and adaptive robotic motion-making automation faster, easier, and significantly more flexible across a wide range of applications. The company’s Scan-to-Path technology is currently deployed in over 6 countries across sectors including aerospace, heavy industry, precision manufacturing, and automotive.

For media inquiries, please contact:

Tan Juanne
Senior Marketing Manager
marketing@augmentus.tech
www.augmentus.tech

SOURCE: Augmentus

View the original press release on ACCESS Newswire

IRS letters targeting digital asset holders are on the rise – Clear Start Tax outlines what crypto traders need to know to protect themselves.

IRVINE, CA / ACCESS Newswire / July 9, 2025 / With the IRS once again sending out crypto-related warning letters, Clear Start Tax is urging digital asset holders to take their reporting obligations seriously. As part of a renewed enforcement push, the IRS is identifying taxpayers who failed to report crypto income and warning them to amend their returns or face possible penalties.

“Many people still assume crypto is anonymous or invisible to the IRS,” said the Head of Client Solutions at Clear Start Tax. “But with new reporting tools, exchange partnerships, and blockchain tracing technology, that’s just not true anymore. The IRS knows more than most traders think – and they’re acting on it.”

Why the IRS Is Targeting Crypto Again in 2025

In 2023 and 2024, the IRS expanded its crypto enforcement tools and increased partnerships with major exchanges. Now, in 2025, those efforts are bearing fruit. Taxpayers are receiving IRS Letter 6173, CP2000 notices, and other correspondence regarding unreported or underreported digital currency transactions.

According to Clear Start Tax, traders may be at risk if they:

• Failed to report crypto sales or conversions on past returns

• Didn’t include staking or mining income

• Used offshore or non-U.S. exchanges without disclosing activity

• Claimed incorrect losses or neglected basis tracking

“These letters aren’t random,” added the Head of Client Solutions. “They’re usually based on real data from exchanges or blockchain analysis. Ignoring them can trigger audits, penalties, or even criminal investigation if the IRS suspects willful evasion.”

Common Crypto Filing Mistakes to Avoid

Even honest filers make errors when it comes to crypto, often because the rules feel unclear. Clear Start Tax highlights some of the most common mistakes that can lead to trouble:

• Not reporting transactions under $10,000 – The IRS requires reporting of all taxable events, no matter the size.

• Using wallet balances instead of transaction history – Gains must be calculated from a cost basis, not just ending value.

• Omitting airdrops or hard forks – These are generally considered taxable income, even if the recipient didn’t request them.

• Mixing personal and business use wallets – Without proper record-keeping, deductions and expenses can be disallowed.

• Failing to file FBAR or Form 8938 – For foreign exchanges, these additional disclosures may apply.

Crypto Traders Can Still Qualify for IRS Relief Programs

Clear Start Tax helps clients file amended returns, respond to crypto notices, and regain IRS compliance. Many investors may still be eligible for penalty relief, interest reduction, or settlement options under the IRS Fresh Start Program.

By answering a few simple questions, taxpayers can find out if they’re eligible for the IRS Fresh Start Program and take the first step toward resolving their tax debt.

This program can be a lifeline for crypto traders looking to fix past mistakes and avoid escalating consequences.

What to Do If You Received a Crypto Letter From the IRS

Traders who’ve received IRS notices like CP2000, Letter 6173, or Letter 6174 should respond quickly. These letters typically flag a discrepancy in reported income and give taxpayers a chance to amend returns or explain the issue.

Clear Start Tax advises:

• Don’t ignore the letter – even if you think it’s incorrect

• Gather exchange records and transaction logs

• Check for cost-basis errors or missing taxable events

• File amended returns if needed

• Consult a professional to ensure proper reporting and penalty mitigation

Don’t Wait for the IRS to Take Action

Clear Start Tax helps crypto investors respond to IRS notices, amend past filings, and bring their accounts into full compliance. In many cases, clients may still qualify for relief through the IRS Fresh Start Program or other negotiated settlements.

About Clear Start Tax

Clear Start Tax is a full-service tax liability resolution firm that serves taxpayers throughout the United States. The company specializes in assisting individuals and businesses with a wide range of IRS and state tax issues, including back taxes, wage garnishment relief, IRS appeals, and offers in compromise. Clear Start Tax helps taxpayers apply for the IRS Fresh Start Program, providing expert guidance in tax resolution. Fully accredited and A+ rated by the Better Business Bureau, the firm’s unique approach and commitment to long-term client success distinguish it as a leader in the tax resolution industry.

Need Help With Back Taxes?

Click the link below:
https://clearstarttax.com/qualifytoday/
(888) 710-3533

Contact Information

Clear Start Tax
Corporate Communications Department
seo@clearstarttax.com
(949) 535-1627

SOURCE: Clear Start Tax

View the original press release on ACCESS Newswire

LOS ANGELES, CA / ACCESS Newswire / July 9, 2025 / HRC Fertility is proud to announce its participation in a groundbreaking clinical trial evaluating Fertilo, an investigational approach to in vitro maturation (IVM) developed by biotechnology innovator Gameto. Fertilo aims to notably reduce the physical, emotional, and financial burden of traditional IVF and egg freezing by maturing eggs outside the body using lab ovarian support cells. This study will compare Fertilo to current in vitro maturation methods, focusing on outcomes like egg quality and pregnancy rates.

The clinical trial reflects HRC Fertility’s ongoing mission to make fertility care more accessible while delivering high level treatment to patients. As a recognized leader in reproductive medicine, HRC Fertility remains dedicated to advancing innovative solutions that support improvement in outcomes and patient experience.

Unlike conventional IVF, which albeit modern in its approach, nonetheless can require two weeks of injections, Fertilo takes an alternative approach by aiming to mimic the natural environment of the ovary but in a lab setting. The goal is a potentially shorter protocol with just five days of oral medication, two injections, and an egg maturation within three days.

HRC Fertility is currently pre screening participants for the GAM-01 Study to further research this clinical trial protocol and outcomes. The trial will be led by Dr. Robert Boostanfar of HRC Fertility’s Valley region, and includes physicians from HRC Fertility’s Beverly Hills and Encino locations including Dr. Shahin Ghadir, Dr. Sasha Hakman, Dr. Rachel Mandelbaum, Dr. Alison Peck, Dr. David Tourgeman, Dr. Sahar Wertheimer, and Dr. Irene Woo. HRC Fertility is one of only a few IVF clinics in the United States to collaborate on this study, and thus far, the only IVF and fertility provider in Los Angeles offering this pioneering program.

“At HRC Fertility, we are proud to be at the forefront of advancing reproductive medicine,” shares Dr. Robert Boostanfar, Board-certified Reproductive Endocrinologist of HRC Fertility and Principal Investigator of the study. “The Fertilo process has the potential to help make IVF more accessible to those who may have been discouraged by physical, emotional, or financial demands,” adding “We are extremely excited to partner with Gameto on this study and look forward to assessing the potential alternative approach further.”

Participants will undergo an abbreviated ovarian stimulation cycle followed by egg retrieval, after which immature eggs will be matured in the lab using the Fertilo process. The resulting embryos can be frozen on day five of development, with an embryo transfer to the patient scheduled within approximately two months.

Generally, participant criteria includes:

• Participants be age 18-35

• Undergoing assisted reproductive treatment

• Body Mass Index (BMI) 21-40

• Normal Uterine Cavity

• Anti-Mullerian Hormone (AMH) > 3 ng/mL

• No endometriosis or presence of endometrioma

• Male partner with adequate semen analysis

As with many studies, costs related to medication, egg retrieval, anesthesia, and frozen embryo transfer will typically be covered by the study sponsor but non-study related costs may not be covered, and study participant guidelines, parameters and restrictions apply.

About HRC Fertility

HRC Fertility is one of the most established providers of advanced IVF and fertility care, with locations across California including Los Angeles, Orange, San Bernardino, San Diego, and the Bay Area, with a Las Vegas location coming soon. For over 35 years, HRC Fertility has remained dedicated to helping hopeful parents preserve their family building options for the future or build families now through world-class assisted reproductive technology, compassion and innovation. For detailed information about HRC Fertility’s services, locations, and providers, please visit www.havingbabies.com.

About Dr. Robert Boostanfar

Dr. Robert Boostanfar, MD, FACOG is a Board-Certified Reproductive Endocrinologist at HRC Fertility’s Valley region seeing patients at the Valley region’s Encino and Westlake Village locations. Dr. Robert Boostanfar is a leading researcher, and earned his undergraduate degree from the University of California, Los Angeles (UCLA) and graduated medical school from the University of Southern California. He completed his residency in Obstetrics and Gynecology in 1999 and his fellowship in the Division of Reproductive Endocrinology and Infertility in 2002 at the USC Los Angeles County Women’s and Children’s Hospital. Dr. Boostanfar has supported patients across spectrums and has been seen on Good Morning America, CNN, TLC, KTLA, CBS People Magazine and Vogue, in addition to a myriad of nominations and awards.

About Gameto

Gameto is a biotechnology company redefining women’s healthcare through cellular engineering. Focused on solving major challenges in reproductive health, Gameto develops therapies that aim to modernize fertility care, ovarian aging, and menopause. Its lead technology, Fertilo, uses lab-grown ovarian support cells to reduce the physical, emotional, and financial strain of traditional IVF and egg freezing. Gameto’s mission is to bring safer, faster, and more accessible fertility solutions to women everywhere.

Contact:

Elainie Andreopoulos
Illumination PR
Elainie@illuminationpr.com

SOURCE: HRC Fertility

View the original press release on ACCESS Newswire

HITRUST certification validates that AGFA HealthCare is operating using leading security practices to protect sensitive information.

MORTSEL, BE / ACCESS Newswire / July 9, 2025 / AGFA HealthCare, a leading provider of Imaging IT, today announced that its Enterprise Imaging Solutions earned certified status by HITRUST for information security.

HITRUST i1 certification demonstrates that AGFA HealthCare’s Enterprise Imaging Solutions are leveraging a comprehensive standard, covering 182 control requirements – including mappings to over 40 authoritative sources – to protect against current and emerging threats. The HITRUST i1 Validated Assessment and Certification allows organizations to demonstrate that they address cybersecurity challenges and remain cyber resilient over time.

“HITRUST i1 Certification gives our internal and external stakeholders confidence that we are following leading security practices,” said Nathalie McCaughley, President at AGFA HealthCare.

Jarius Jackson, Data Protection Officer and Security & Privacy Technical Specialist at AGFA HealthCare, further comments: “Practicing strong cybersecurity is critical to minimize information security risk and protect our organization and partners. The certification demonstrates our commitment to high standards for cybersecurity and data protection.”

“The HITRUST i1 Validated Assessment is a powerful tool for cyber-aware organizations, such as AGFA HealthCare”, said Robert Booker, Chief Strategy Officer at HITRUST. “HITRUST i1 Certification provides measurement, implementation, and performance assurance of information security controls. Congratulations to AGFA HealthCare for earning HITRUST i1 Certification and demonstrating the operational maturity of their cybersecurity program.”

---

About AGFA HealthCare

At AGFA HealthCare, we are transforming the delivery of care – supporting healthcare professionals across the globe with secure, effective, and sustainable imaging data management. As a company, we are dedicated to our customers, and we have harnessed a value framework of Mission, Vision and Customer Delivery Principles into our routine operations. Through these principles, we commit a consistent high-yield code of conduct to our associates – channeling our experience and aspirations to all of our stakeholders. Our Empowerer profile supports our focus on creating an exceptional experience through the power of technology and is an integral foundation to our company standards. AGFA HealthCare is a division of the Agfa-Gevaert Group. For more information on AGFA HealthCare, please visit www.agfahealthcare.com and follow us on LinkedIn.

AGFA and the Agfa rhombus are registered trademarks of Agfa-Gevaert N.V. Belgium or its affiliates. All information contained herein is intended for guidance purposes only, and the characteristics of the products and services described in this publication can be changed at any time without notice. Products and services may not be available for your local area. Please contact your local sales representative for availability information. AGFA HealthCare diligently strives to provide as accurate information as possible but shall not be responsible for any typographical error.

SOURCE: AGFA HealthCare

View the original press release on ACCESS Newswire

VANCOUVER, BC / ACCESS Newswire / July 8, 2025 / North Shore Uranium Ltd. (TSX-V:NSU) (“North Shore” or the “Company“) is pleased to announce that it has entered into an advertising and investor awareness campaign agreement (the “INN Agreement“) with Dig Media Inc. dba Investing News Network (“INN“).

INN is a private company headquartered in Vancouver, Canada, dedicated to providing independent news and education to investors since 2007 at www.investingnews.com. On July 4, 2025, the Company entered into the INN Agreement. The INN Agreement will be for a three-month term, with three equal payments of $2,750 that will be paid at the beginning of each month, totaling $8,250 (GST excluded). The INN Agreement will not automatically renew. INN will provide advertising to increase awareness of the Company with the first campaign commenced on July 4, 2025. INN does not provide Investor Relations or Market Making services. INN currently holds no common shares in the Company. INN and the Company are unrelated and unaffiliated entities.

The INN Agreement is subject to approval by the TSX Venture Exchange.

ABOUT NORTH SHORE

The nuclear power industry is in growth mode as more nuclear power will be required to meet the world’s ambitious CO₂ emission-reduction goals and the needs of new power-intensive technologies like AI. In this environment, new discoveries of economic uranium deposits will be very valuable, especially in established uranium-producing jurisdictions like Saskatchewan and New Mexico (see news release dated June 24, 2025). North Shore is well-positioned to become a major force in exploration for economic uranium deposits. The Company is working to achieve this goal by exploring its Falcon and West Bear properties at the eastern margin of the Athabasca Basin in Saskatchewan, expanding its exploration efforts to include the Grants Uranium District in New Mexico and by evaluating other quality opportunities in the United States and Canada to complement its portfolio of uranium properties. North Shore summarized exploration efforts at its Falcon property in a May 27, 2025, news release.

ON BEHALF OF THE BOARD

Brooke Clements,
President, Chief Executive Officer and Director

For further information:
Please contact: Brooke Clements, President, Chief Executive Officer and Director
Telephone: 604.536.2711
Email: b.clements@northshoreuranium.com
www.northshoreuranium.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains forward-looking statements that are based on the Company’s current expectations and estimates. Forward-looking statements are frequently characterized by words such as “plan”, “project”, “appear”, “interpret”, “coincident”, “potential”, “confirm”, “suggest”, “evaluate”, “encourage”, “likely”, “anomaly”, “continuous” and variations of these words as well as other similar words or statements that certain events or conditions “could”, “may”, “should”, “would” or “will” occur. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause actual events or results to differ materially from estimated or anticipated events or results implied or expressed in such forward-looking statements. Such factors include, among others: the completion of the Offering; the completion and expected terms of the Transaction, the parties’ abilities to meet the closing conditions of the Transaction, the number of securities to be issued by the Company in connection with the Transaction, receipt of all necessary approvals for the completion of the Transaction, the completion of satisfactory due diligence, execution of a definitive agreement, and the Company’s ability to meet the terms of the Transaction; the highly speculative nature of the Transaction given the early-stage nature of Rio Puerco; the actual results of current and planned exploration activities including the potential for the definition of a mineral deposit of potential economic value at the Company’s Falcon property in Saskatchewan; that drilling results, geophysical survey results and/or interpretations thereof are defining potentially mineralized corridors; results from future exploration programs including drilling; interpretation and meaning of completed and future geophysical surveys; conclusions of future economic evaluations; changes in project parameters as plans to continue to be refined; possible variations in grades of mineralization and/or future actual recovery rates; accidents, labour disputes and other risks of the mining industry; the availability of sufficient funding on terms acceptable to the Company to complete the planned work programs; delays in obtaining governmental approvals or financing; and fluctuations in metal prices. There may be other factors that cause actions, events or results not to be as anticipated, estimated, or intended. Any forward-looking statement speaks only as of the date on which it is made and, except as may be required by applicable securities laws, the Company disclaims any intent or obligation to update any forward-looking statement, whether as a result of new information, future events, or results or otherwise. Forward-looking statements are not guarantees of future performance and accordingly undue reliance should not be put on such statements due to the inherent uncertainty therein. Any forward-looking statements contained in this news release are expressly qualified in their entirety by this cautionary statement.

SOURCE: North Shore Uranium Ltd.

View the original press release on ACCESS Newswire

A New York foreclosure case involving a previously satisfied mortgage led to a key Appellate Division ruling. The court upheld the rights of a third-party property owner to intervene and rejected the bank’s insufficient evidence. Petroff Amshen LLP, serving as Foreclosure Defense Attorneys, secured a critical procedural victory and defended the integrity of recorded satisfactions.

NEW YORK CITY, NY / ACCESS Newswire / July 8, 2025 / Imagine transferring a property years after a mortgage is officially marked “satisfied”-only to be pulled back into court when a bank claims it was all a mistake. That’s the legal trap a New York buyer faced in a recent foreclosure dispute, one where Petroff Amshen LLP stepped in to defend ownership, title integrity, and consumer protection.

The Mortgage That Shouldn’t Have Been There

In 2003, a home equity line of credit was issued for a residential property in Queens Village. Over a decade later, the bank-the successor to the original lender-recorded a satisfaction of mortgage, formally signaling that the debt was resolved.

But in 2016, the bank initiated a foreclosure action against the property, claiming that the satisfaction had been filed in error. By that point, the home had already been transferred to a third party who purchased it in good faith, relying on the public record.

What The Court Actually Said

In a recent decision from the Appellate Division, Second Judicial Department, the court addressed multiple core issues, ruling in favor of the current owner and affirming the legal boundaries banks must follow when disputing satisfied mortgages.

The decision also underscores the role of experienced Foreclosure Defense Attorneys in protecting property owners when procedural errors or unsubstantiated claims threaten their legal rights.

Key rulings included:

• The third-party buyer had the right to intervene in the foreclosure case as the current legal titleholder.

• The bank failed to submit sufficient admissible evidence to override the public record.

• The court raised factual issues regarding residency status, leaving the door open for consumer protections under RPAPL 1304.

• The bank could not establish standing to bypass standard foreclosure notice requirements.

Why This Case Matters To Property Owners And Buyers

If a mortgage can be “un-discharged” years after being marked satisfied, without concrete proof, any homeowner or property investor is at risk. The court’s position highlights the importance of trusting recorded satisfactions and ensuring that banks meet their legal burden.

“A satisfaction of mortgage is more than paperwork-it’s the legal conclusion of a debt,” said Steven Amshen, Founding Partner of Petroff Amshen LLP. “We fought to ensure that banks cannot undo their own filings just because they changed their minds years later.”

Petroff Amshen LLP: Defending The Finality Of Title

Petroff Amshen LLP represented the third-party buyer in the appeal, challenging the foreclosure and preserving title rights that had been lawfully acquired. As Foreclosure Defense Attorneys, the firm emphasized:

• The legal presumption created by recorded mortgage satisfactions

• The lender’s failure to present verifiable facts

• The importance of statutory compliance in foreclosure proceedings

The case affirms the right of consumers and buyers to rely on official public filings-and the power of legal intervention when those records are contested.

Legal Closure Means Legal Peace

This decision reinforces the role of Foreclosure Defense Attorneys not only in stopping sales, but in upholding ownership rights and legal certainty in cases involving administrative errors or record conflicts. Petroff Amshen LLP advises homeowners and buyers to seek legal counsel immediately if they receive notice of foreclosure involving a previously satisfied mortgage.

Stay connected with Petroff Amshen LLP for legal alerts and victories:

Instagram: @petroffamshen

Facebook: Petroff Amshen LLP

LinkedIn: Petroff Amshen LLP | New York

SOURCE: Petroff Amshen LLP

View the original press release on ACCESS Newswire

NEW YORK CITY, NEW YORK / ACCESS Newswire / July 8, 2025 / New to The Street, the award-winning national TV business show airing weekly as sponsored programming on Fox Business and Bloomberg, proudly announces comprehensive coverage of BitMine Immersion Technologies Inc. (NASDAQ:BMNR) following its groundbreaking $250 million private placement and Ethereum treasury strategy.

As part of this expanded visibility initiative, BitMine Immersion Technologies will be featured across New to The Street’s multi-platform media network. Coverage includes exclusive interviews, national broadcast segments, and a dedicated NewsOut™ Video Press Release, which will be distributed across over 3 million YouTube subscribers, major business media platforms, and social media syndication on X, LinkedIn, Instagram, and Facebook.

This announcement comes on the heels of BitMine’s strategic pivot to become one of the world’s largest publicly traded holders of Ethereum (ETH). With the appointment of Tom Lee, Founder of Fundstrat and globally respected macro strategist, as Chairman of the Board, BitMine is redefining its identity from a mining operator to a bold digital asset treasury company.

“BitMine’s transformative move into ETH-backed treasury strategy aligns with the type of innovation we spotlight,” said Vince Caruso, Founder and CEO of New to The Street. “Our team is thrilled to cover BitMine at this pivotal moment in its corporate evolution and amplify this milestone with NewsOut’s high-impact PR format.”

The NewsOut segment will feature a concise visual summary of BitMine’s latest developments, including its Ethereum strategy, capital raise, and leadership shift. In tandem, full-length interviews will be broadcast on Bloomberg and Fox Business, bringing BitMine’s story directly to retail and institutional investors alike.

Coverage Includes:

• Televised Interview Broadcasts: Bloomberg (Saturday 6:30 PM EST) & Fox Business (Monday 10:30 PM EST)

• NewsOut Video Press Release: Distributed via YouTube, X, LinkedIn, and financial news wires

• Social Media Amplification: 30 days of digital promotion across New to The Street’s channels

• Earned Media Syndication: Sent to ABC, NBC, and CBS financial affiliates nationwide

As BitMine accelerates its Ethereum acquisition strategy, investor interest continues to surge, with shares rising over 1,000% in the past week.

For more information on BitMine Immersion Technologies Inc., visit: bitminetech.io
To watch the NewsOut Video Press Release and broadcast segments, subscribe to: www.YouTube.com/@NewToTheStreetTV

About New to The Street

Where Innovation Meets Influence

New to The Street is one of the most recognized and enduring business television brands in the U.S., delivering award-winning sponsored programming on premier networks including Fox Business and Bloomberg Television. With 3+ million YouTube subscribers, 18 years of uninterrupted broadcasting, and a growing global footprint, we serve as the definitive media platform for both emerging and established public companies.

Each week, we feature long-form interviews with CEOs, visionaries, and market leaders-filmed from the floors of the New York Stock Exchange, the Nasdaq MarketSite, and other iconic financial centers. Our content is further amplified across national television, NYC’s most prominent billboards, and a 500,000+ follower investor-focused social media network across X, LinkedIn, Facebook, and Instagram.

We don’t just offer visibility-we deliver Opportunity Awareness™. Whether spotlighting biotech innovation or blockchain transformation, New to The Street provides the credibility, scale, and distribution to elevate companies-and inform investors-at the moments that matter most.

New to The Street
Trusted. Syndicated. Unrivaled.

www.NewToTheStreet.com
YouTube: @NewtotheStreetTV

---

Media Contact:
Monica Brennan
Director of Media Relations, New to The Street
Monica@NewToTheStreet.com

SOURCE: New To The Street

View the original press release on ACCESS Newswire

AUSTIN, TX / ACCESS Newswire / July 8, 2025 / Curative Insurance Company is proud to announce that AM Best, the global credit rating agency specializing in the insurance industry, has affirmed its A- (Excellent) Financial Strength Rating (FSR) and Long-Term Issuer Credit Rating (Long-Term ICR) of “a-” (Excellent) for the third consecutive year. This affirmation reflects Curative’s continued financial stability, robust risk-adjusted capitalization, and commitment to its innovative employer-based health plan.

According to AM Best, their FSR rating is an independent opinion of an insurer’s financial strength and ability to meet its ongoing insurance policy and contract obligations. An A- rating is assigned to insurance companies that have, in AM Best’s opinion, an excellent ability to meet their ongoing insurance obligations. ICRs are based on a company’s ability to meet its ongoing financial obligations and can be issued either on a long or short-term basis. Curative’s “a-” Long-Term ICR ratings mean that AM Best believes that Curative has an excellent ability, over the long term, to meet their ongoing senior financial obligations.

“We are honored to maintain our A- rating from AM Best for another year,” said Tami Wilson-Ciranna, President and CFO of Curative. “This recognition underscores our commitment to building a financially sound and innovative health insurance model that prioritizes simplicity and affordability for our members. As we continue to grow and execute our vision, this affirmation strengthens confidence in our ability to deliver on our mission.”

Curative’s significant growth, market expansion, and strong financial footing was driven by its strategic emphasis on its employer-based health insurance plans – offering $0 copays, deductibles, and out-of-pocket costs for in-network services.* The company’s investments in innovative features such as the Curative Zero Card and the PPO-Max offering have also been pivotal in supporting its unique business model.

Curative launched its first-of-its-kind health plan in 2023 and has since expanded its reach to employers across multiple states. The company remains committed to transforming health insurance by eliminating financial barriers to care while fostering member engagement through preventive health measures.

To learn more about Curative Insurance Company, its revolutionary health insurance plan, and how it can benefit employers and employees alike, visit https://curative.com.

*​​Every Curative member qualifies for the $0 deductible, $0 copay for in-network care and preferred prescriptions by completing a Baseline Visit within 120 days of the plan effective date.

ABOUT AM BEST

AM Best is a global credit rating agency specializing in the insurance industry. Headquartered in the United States, AM Best operates in over 100 countries with regional offices worldwide. For more information, visit www.ambest.com.

ABOUT CURATIVE

Curative is creating the future of health insurance with its first-of-a-kind employer-based plan, boasting an impressive AM Best rating of A-. Our mission is to transform health insurance by eliminating financial barriers to care and guiding our members at every step of their health journey. With a competitive monthly premium and zero additional costs*, Curative provides employers and their employees exceptional value, improved health, and peace of mind. Leveraging our experience from leading the national COVID-19 testing effort, Curative is now redefining health insurance through affordability, engagement, and simplicity. For more information on Curative, visit https://curative.com or follow us on Facebook, Instagram, X, or LinkedIn.

Media Contact Name: Mackenzie Light
Email: mackenzielight@curative.com

SOURCE: Curative Health Insurance

View the original press release on ACCESS Newswire